%0 Journal Article
%T Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
%A Caroline Piatek
%A Elizabeth Pan
%A Eric Hsieh
%J Archive of "Case Reports in Oncology".
%D 2018
%R 10.1159/000495032
%X Thrombocytopenia is a frequent complication of cancer may be due to a variety of causes including malignancy itself, acute disease processes, or cancer therapy. Systemic cancer therapy is the most common cause of thrombocytopenia in cancer patients observed nearly two-thirds of patients with solid tumors. Thrombocytopenia with traditional chemotherapy agents is most frequently the result of megakaryocyte cytotoxicity. Oxaliplatin is a platinum derivative commonly used in gastrointestinal malignancies and is associated with drug-induced immune thrombocytopenia
%K Adenocarcinoma
%K Oxaliplatin
%K Thrombocytopenia
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341312/